Computational Models for Ocular Drug Repurposing of a Ribosomal S6 Kinase Inhibitor (RSKi) in Treatment of Retinal Degenerative Diseases

被引:0
|
作者
Mikayelyan, Lilit [1 ]
Terneus, Marcus [2 ]
Bramhall, Jessica [2 ]
Bell, Sammy [2 ]
Gukasyan, Hovhannes J. [1 ]
机构
[1] Univ Southern Calif, Mann Sch Pharm & Pharmaceut Sci, Los Angeles, CA USA
[2] Boehringer Ingelheim Pharmaceut Inc, External Alternat CMC Dev, Ridgefield, CT USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
6128
引用
收藏
页数:2
相关论文
共 33 条
  • [21] Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolution
    Derewenda, Urszula
    Artamonov, Mykhaylo
    Szukalska, Gabriela
    Utepbergenov, Darkhan
    Olekhnovich, Natalya
    Parikh, Hardik I.
    Kellogg, Glen E.
    Somlyo, Avril V.
    Derewenda, Zygmunt S.
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2013, 69 : 266 - 275
  • [22] Phospholipase Cε Activates Nuclear Factor-κB Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor κB in Colon Epithelial Cells
    Wakita, Masahiro
    Edamatsu, Hironori
    Li, Mingzhen
    Emi, Aki
    Kitazawa, Sohei
    Kataoka, Tohru
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (24) : 12586 - 12600
  • [23] Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells
    Boulay, A
    Zumstein-Mecker, S
    Stephan, C
    Beuvink, I
    Zilbermann, F
    Haller, R
    Tobler, S
    Heusser, C
    O'Reilly, T
    Stolz, B
    Marti, A
    Thomas, G
    Lane, HA
    CANCER RESEARCH, 2004, 64 (01) : 252 - 261
  • [24] Identification of Inhibitors against p90 Ribosomal S6 Kinase 2 (RSK2) through Structure-Based Virtual Screening with the Inhibitor-Constrained Refined Homology Model
    Li, Shiliang
    Zhou, Yi
    Lu, Weiqiang
    Zhong, Ye
    Song, Wenlong
    Liu, Kangdong
    Huang, Jin
    Zhao, Zhenjiang
    Xu, Yufang
    Liu, Xiaofeng
    Li, Honglin
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (11) : 2939 - 2947
  • [25] Tributylhexadecylphosphonium Bromide, a Novel Nuclear Factor of Activated T Cells Signaling Inhibitor, Blocks Interleukin-2 Induction Associated with Inhibition of p70 Ribosomal Protein S6 Kinase Phosphorylation
    Umehara, Hiroshi
    Asai, Akira
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (05) : 805 - 809
  • [26] Combined inhibition of EGFR and protein kinase CK2 synergistically blocks phosphorylation of ribosomal protein S6, induces apoptosis in cancer cells and displays enhanced antitumor activity in xenograft models
    Drygin, D.
    Bliesath, J.
    Siddiqui-Jain, A.
    Huser, N.
    Omori, M.
    Streiner, N.
    Proffitt, C.
    Ho, C.
    O'Brien, S.
    Anderes, K.
    EJC SUPPLEMENTS, 2010, 8 (07): : 39 - 39
  • [27] Discovery of novel p90 ribosomal S6 kinase 2 inhibitors for potential cancer treatment through ligand-based and structure-based virtual screening methods
    Zhao, Yue
    Chen, Rui-fang
    Deng, Zhen-Ke
    Zhang, Liu-Xia
    Cheng, Yan
    Chen, Alex F.
    Cao, Dong-Sheng
    CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2021, 217
  • [28] PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1
    Park, Jeong Su
    Kang, Dong Hoon
    Lee, Da Hyun
    Bae, Soo Han
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 466 (03) : 499 - 504
  • [29] Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)
    Reipas, Kristen M.
    Law, Jennifer H.
    Couto, Nicole
    Islam, Sumaiya
    Li, Yvonne
    Li, Huifang
    Cherkasov, Artem
    Jung, Karen
    Cheema, Amarpal S.
    Jones, Steven J. M.
    Hassell, John A.
    Dunn, Sandra E.
    ONCOTARGET, 2013, 4 (02) : 329 - 345
  • [30] Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK):: Effects of the novel and specific RSK inhibitor fmk on responses to α1-adrenergic stimulation
    Cuello, Friederike
    Snabaitis, Andrew K.
    Cohen, Michael S.
    Taunton, Jack
    Avkiran, Metin
    MOLECULAR PHARMACOLOGY, 2007, 71 (03) : 799 - 806